AGP Executive Report
Last update: 8 hours agoWeight-loss ad lawsuit: Novo Nordisk is suing Eli Lilly over “false and materially misleading” weight-loss and diabetes ads, accusing Lilly of using outdated study comparisons and burying key context. Policy & access: Spain’s Council of Ministers approved a draft Medicines and Health Products law that changes how medicines are financed and aims to reduce supply shortages. Counterfeit/food safety: The U.S. FDA and CDC are tracking a cyclospora outbreak tied to shredded iceberg lettuce from Taylor Farms, after a prior positive test was later deemed a false alarm; Michigan reports thousands of cases. Clinical trial progress: Envoy Medical says all 56 patients hit the three-month milestone in its pivotal Acclaim cochlear implant trial as it works toward an FDA PMA submission. Healthcare business moves: Fresenius Medical Care launched TherapyWise Analytics to help clinicians optimize kidney replacement therapy using cloud-based insights. Community health: Azerbaijan repatriated 16 people from Syria and provided initial medical and psychosocial support. Care delivery expansion: CVS will now dispense select pet prescriptions at thousands of stores. Global health workforce: BRICS nations agreed to create a working group on traditional, complementary and integrative medicine.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.